Horizon Aircraft (HOVR) Q3 2026 earnings review
Heavy R&D Investment Accelerates as Full-Scale Assembly Begins
Horizon Aircraft remains a pre-revenue, show-me story. Q3 FY26 results reflect an accelerating cash burn as the company transitions from sub-scale testing to building its full-scale Cavorite X7 demonstrator. R&D expenses surged nearly 10x year-over-year to $4.3M CAD, driving a total net loss of $6.9M CAD (EPS -$0.16). While the company secured vital non-dilutive government funding (INSAT) and ended the quarter with $19.7M CAD in cash—providing at least 12 months of runway—investors are footing the bill. Ongoing ATM equity sales and hefty stock-based compensation have expanded the share count by 39% over the past nine months.
🐂 Bull Case
The massive acceleration in engineering and R&D spend indicates genuine progress toward the full-scale Cavorite X7 prototype, with flight testing firmly targeted for 2027.
Selection for the Canadian government's INSAT program ($10.5M project pool, up to 40% reimbursed) provides both a capital lifeline and crucial third-party technical validation for Horizon's hybrid-electric architecture.
🐻 Bear Case
Outstanding Class A shares grew from 32.3M in May 2025 to 45.0M in February 2026. With $33.4M USD remaining on the ATM, current shareholders face continuous dilution to fund operations.
Despite $19.7M CAD in the bank, management explicitly notes substantial doubt about continuing beyond 12 months without raising more capital. Hardware commercialization is brutally expensive.
⚖️ Verdict: ⚪
Neutral. Horizon is executing exactly what a pre-revenue aviation startup should do: aggressively spending on engineering to hit technical milestones. However, the sheer cost of this phase guarantees severe equity dilution for early investors.
Key Themes
R&D Spending Accelerating for Full-Scale Build
Research and development costs jumped significantly to $4.28M CAD in Q3 (up from $0.44M a year ago), representing an accelerating trend. This is a deliberate and necessary surge: engineering costs accounted for $1.36M of this, while R&D compensation hit $2.89M as the company doubles down on fabricating the full-scale Cavorite X7 demonstrator. This spending is the primary engine driving Horizon toward its 2027 flight-test catalyst.
Sustained G&A Bloat Contradicts Efficiency Narrative
In Q1, management claimed they had 'streamlined operations... to reduce administrative costs relative to total costs.' However, Q3 data contradicts this: General & Administrative expenses came in at $3.31M CAD, eating up 43% of total operating expenses. This was heavily driven by executive compensation and an aggressive $3.79M CAD non-cash charge for Performance Share Units (PSUs) issued in February. True capital efficiency remains elusive when stock-based compensation rivals direct aircraft engineering spend.
Macro Tailwind: Green Aerospace Subsidies
Horizon successfully tapped into macro-level ESG and sustainable aviation subsidies. The approval for the Canadian government's INSAT fund allows Horizon to recoup up to 40% of a $10.5M CAD development project over the next 1-2 years. Alongside DAIR Green Fund grants, this non-dilutive capital is a critical driver to offset the massive cash burn associated with scaling hybrid-electric eVTOL technology.
Accelerating Shareholder Dilution
To maintain liquidity, management is aggressively tapping the equity markets. The company raised $21.4M CAD in the first nine months of FY26 via its Capital on Demand Sales Agreement, selling 6.87 million shares. Combined with warrant exercises and incentive shares, outstanding Class A shares have expanded from 32.3M to 45.0M in just nine months. With $33.4M USD still available under the ATM, this dilutive trajectory is stable and highly likely to continue.
Dual-Use Military Strategy Bypasses Bottlenecks
A key strategic driver is Horizon's deliberate positioning of the Cavorite X7 as a dual-use (civilian and military) vehicle. Management explicitly noted that aircraft sold to NATO/military customers do not require traditional FAA or Transport Canada Civil Aviation (TCCA) certification. This dramatically reduces the path-to-revenue timeline and mitigates the severe regulatory risk associated with civilian eVTOL certification.
Other KPIs
Stable compared to the prior quarter, but up significantly from $7.5M CAD at the end of FY25. This liquidity buffer was built through aggressive ATM usage and warrant exercises. It clears the immediate 'going concern' risk for the next 12 months, but management acknowledges more capital will be required beyond that.
Cash burn is accelerating. The outflow widened sharply from -$6.81M CAD in the same nine-month period last year. This reflects the reality of hardware scale-up: higher payroll, costly materials for the prototype, and increased software/simulation expenses.
Guidance
Stable. The timeline for testing the full-scale Cavorite X7 remains locked on early-to-mid 2027. Meeting this milestone without slippage is the single most critical event for the company's valuation.
Stable. Management estimates current cash on hand will fund the operating plan for at least 12 months from the report issuance (April 2027), lining up almost exactly with the expected initial testing phase. Capital raises will likely need to accelerate if testing uncovers costly redesign needs.
Key Questions
INSAT Cash Flow Timing
You've been approved for the INSAT grant to reimburse up to 40% of a $10.5M CAD project. What is the precise timing of these cash inflows, and are they contingent on specific engineering milestones?
Managing the ATM Overhang
With $33.4M USD remaining on your ATM facility, how do you plan to balance the necessary capital raises for the 2027 prototype test against the fatigue of persistent equity dilution for current shareholders?
G&A Expense Control
General and administrative expenses remain highly elevated, driven by significant PSU-related stock compensation. When can investors expect to see G&A scale down as a percentage of total operating expense to reflect a leaner, engineering-first culture?